Adamas to present at upcoming icr conference

Emeryville, calif., jan. 07, 2021 (globe newswire) -- adamas pharmaceuticals, inc. (nasdaq: adms), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that neil f. mcfarlane, chief executive officer, will participate in a fireside chat at the icr conference 2021, being held january 11-14, 2021.

ADMS Ratings Summary

ADMS Quant Ranking